Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/01/2005WO2005113805A2 Assays for the identification of modulators of mhc class ii expression
12/01/2005WO2005113804A1 Use of mass labelled probes to detect target nucleic acids using mass spectrometry
12/01/2005WO2005113803A1 Detection of amplicon contamination during pcr exhibiting two different annealing temperatures
12/01/2005WO2005113802A2 Genotoxic testing
12/01/2005WO2005113801A2 Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib
12/01/2005WO2005113800A2 Method and device for monitoring aspirin response
12/01/2005WO2005113799A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 5 (grk5)
12/01/2005WO2005113798A2 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
12/01/2005WO2005113797A2 METHODS FOR DETECTING Lp-PLA2 ACTIVITY AND INHIBITION OF Lp-PLA2 ACTIVITY
12/01/2005WO2005113796A1 Biological soil detector and method of using same
12/01/2005WO2005113795A2 Hematology reference control containing an immature granulocyte component
12/01/2005WO2005113794A1 Methods and tools for detecting collagen degradation
12/01/2005WO2005113793A1 Method for introducing protein and/or peptide into cell
12/01/2005WO2005113792A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same
12/01/2005WO2005113791A2 Methods of identifying modulators of bacterial type iii protein secretion system
12/01/2005WO2005113790A1 Electrochemical assay device and related methods
12/01/2005WO2005113789A2 Method for identifying compounds that have the ability to inhibit the activity of myc
12/01/2005WO2005113788A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6)
12/01/2005WO2005113787A2 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 1 (grk1)
12/01/2005WO2005113786A2 Diagnostics and therapeutics for diseases associated with chymase (cma1)
12/01/2005WO2005113773A1 Polynucleotides for the detection of escherichia coli 0157:h7 and escherichia coli 0157:nm verotoxin producers
12/01/2005WO2005113769A1 Method for stabilizing biological samples for nucleic acid analysis
12/01/2005WO2005113767A1 Plasmid responsive to dioxin, etc., transgenic cell for assay of dioxin, etc. and utilizing the same, dioxin, etc. detecting method and biosensor
12/01/2005WO2005113740A2 Perfusion system and apparatus for automated multi-channel patch-clamp recordings utilizing inside-out whole-cell configuration
12/01/2005WO2005113599A1 C1q family member proteins with altered immunogenicity
12/01/2005WO2005113592A2 Interferon-alpha polypeptides and conjugates
12/01/2005WO2005113586A2 Disease-associated proteins
12/01/2005WO2005113148A1 Single molecule amplification and detection of dna length
12/01/2005WO2005113147A2 Integration of sample storage and sample management for life science
12/01/2005WO2005112997A2 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues
12/01/2005WO2005112975A1 Use of histones for the early diagnosis and/or preventative therapy of virally-infected living cells and a biochip for carrying out said diagnosis
12/01/2005WO2005112906A2 Method for augmenting the effects of serotonin reuptake inhibitors
12/01/2005WO2005112628A2 Sptrx-3 polypeptide and nucleic acid. uses thereof in methods and compositions for evaluation of male fertility
12/01/2005WO2005112568A2 Haplotype markers and methods of using the same to determine response to treatment
12/01/2005WO2005112544A2 Leptin promoter polymorphisms and uses thereof
12/01/2005WO2005099335A3 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
12/01/2005WO2005098040A8 Ligation and amplification reactions for determining target molecules
12/01/2005WO2005095653A3 Method for collecting purified cells
12/01/2005WO2005092059A3 Compositions for use in identification of viral hemorrhagic fever viruses
12/01/2005WO2005087951A3 Reagents, methods and kits for use in deactivating nucleic acids
12/01/2005WO2005082930A3 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
12/01/2005WO2005080603A3 Single molecule detection using molecular motors
12/01/2005WO2005078125A3 Itpase gene polymorphisms associated with adverse drug reactions to azathioprine therapy
12/01/2005WO2005075673A3 Detection, identification and differentiation of proteus species using the spacer region
12/01/2005WO2005073408A3 Small segments of dna determine animal identity and source
12/01/2005WO2005071401A3 Homogeneous multiplex assay for nucleic acid targets
12/01/2005WO2005069975A3 Lysyl oxidase-like 1 (loxl1) and elastogenesis
12/01/2005WO2005067643A8 Determination of hepatitis c virus genotype
12/01/2005WO2005058938A3 Helical synthetic peptides that stimulate cellular cholesterol efflux
12/01/2005WO2005057212A3 Device for sensing contaminants
12/01/2005WO2005057169A3 Homogeneous competition assays
12/01/2005WO2005054509A3 Assay and treatment
12/01/2005WO2005051977A3 Conditional allele system
12/01/2005WO2005027831A3 Modulators of p-selectin glycoprotein ligand 1
12/01/2005WO2005026191A3 Size-controlled macromolecule
12/01/2005WO2005024043A3 Methods for identifying, diagnosing, and predicting survival of lymphomas
12/01/2005WO2005019251A8 Novel fungal proteins and nucleic acids encoding same
12/01/2005WO2005016126A3 Multifactorial assay for cancer detection
12/01/2005WO2005014858A3 Qtl 'mapping as-you-go'
12/01/2005WO2005010794A3 Method for determining metabolic flux affecting substance production
12/01/2005WO2005003305A3 Usps as modifiers of the beta catenin pathway and methods of use
12/01/2005WO2005001032A3 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection
12/01/2005WO2004111262A8 Method of identifying a selective chemotherapeutic agent
12/01/2005WO2004079002A8 Lab-on-chip system for analying nucleic acid
12/01/2005WO2004072259A8 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
12/01/2005WO2004070001A3 Assay and compositions for detection of bacillus anthracis nucleic acid
12/01/2005WO2004066949A3 Antisense oligonucleotides that inhibit expression of hif-1
12/01/2005WO2004026804A8 Anthraquinone quencher dyes, their methods of preparation and use
12/01/2005WO2004020979A3 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
12/01/2005WO2003064588A3 Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
12/01/2005US20050268359 Plant centromere compositions
12/01/2005US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals
12/01/2005US20050267693 Method, system, and apparatus for compactly storing a subject genome
12/01/2005US20050267692 Method and system for the detection of atypical sequences via generalized compositional methods
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267059 Syk-targeted nucleic acid interference
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267029 Compounds which modulate amyloidogenesis and methods for their identification and use
12/01/2005US20050267025 Compositions and methods for treatment of infectious and inflammatory diseases
12/01/2005US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
12/01/2005US20050266568 Molecule-releasing apparatus and molecule-releasing medhod
12/01/2005US20050266563 Methods and compositions relating to neuronal cell and tissue differentiation
12/01/2005US20050266552 Reagents and methods for identification of RNAi pathway genes and chemical modulators of RNAi
12/01/2005US20050266541 Methods and compositions for evolving microbial hydrogen production
12/01/2005US20050266516 System for rapid analysis of microbiological materials in liquid samples
12/01/2005US20050266515 Glyceraldehyde 3-phosphate dehydrogenase-S (GAPDHS), a glycolytic anzyme expressed only in male germ cells, is a target for male contraception
12/01/2005US20050266514 used to quickly diagnose infections with gram-negative bacteria (as Escherichia coli) or with fungi (as Candida albicans)
12/01/2005US20050266513 Method for identifying compounds that inhibit the activity of Myc
12/01/2005US20050266512 Detection of proteases and screening for protease inhibitors
12/01/2005US20050266511 High throughput sarcomeric assay
12/01/2005US20050266510 T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase
12/01/2005US20050266509 Interaction of NMDA receptor with protein tyrosine phosphatase
12/01/2005US20050266508 Detection of potassium ions using ion-sensitive enzymes
12/01/2005US20050266505 Compound with a hydroxamate and a benzophenone group, and a functional group of rhodamine, oligonucleotides, azides, alkynes, biotin, or p-nitrophenyl; binding the active compound to the active site, forming an active compound-metalloprotease adduct; determining the potency of the inhibitor
12/01/2005US20050266502 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/01/2005US20050266498 Method for screening biomolecule activity regulator
12/01/2005US20050266494 System and method for computer network ordering of biological testing
1 ... 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 ... 3003